Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

AIDS

Volumn 12, Issue 10, 1998, Pages 1149-1154

  Albrecht, Helmut ^a,b,e   Hoffmann, Christian ^b   Degen, Olaf ^b,d   Stoehr, Albrecht ^c   Plettenberg, Andreas ^c   Mertenskötter, Thomas ^d   Eggers, Christian ^b   Stellbrink, Hans Jürgen ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral; Highly active antiretroviral therapy; Neurological manifestation; Progressive multifocal leukoencephalopathy

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CYTARABINE; FOSCARNET; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOENCEPHALOPATHY; LYMPHOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; BRAIN; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 0032499933     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199810000-00006     Document Type: Article

References (46)

1. Berger JR, Kaszovitz B, Post MJ, Dickinson G: Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of 16 cases. Ann Intern Med 1987, 107:78-87.
2. Gillespie SM, Chang Y, Lemp G, et al.: Progressive multifocal leukoencephalopathy in persons infected with the immunodeficiency virus, San Francisco 1981-1989. Ann Neurol 1991, 30:597-604.
3. Fong IW, Toma E, Canadian PML Study Group: The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995, 20:1305-1310.
4. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M: 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy [letter]. Lancet 1997, 349:850.
5. Baqi M, Kucharczyk W, Walmsley SL: Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy [letter]. AIDS 1997, 11:1526-1527.
6. Power C, Nath A, Aoki FY, Del Bigio M: Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997, 336:661-662.
7. Domingo P, Guardoliola JM, Iranzo A, Margall N: Remission of multifocal leucoencephalopathy after antiretroviral therapy. Lancet 1997, 349:1554-1555.
8. Weber T, Turner RW, Frye S, et al.: Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994, 169:1138-1141.
9. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC: Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 1991, 41:1733-1736.
10. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J: Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neural 1985, 17:344-349.
11. Major EO, Ault CS: Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995, 8:184-190.
12. Whiteman ML, Post JD, Berger JR, Tate LG, Bell MD, Limonte LP: Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993, 187:233-240.
13. Martinez AJ, Sell M, Mitrovics T: The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases. Pathol Res Pract 1995, 191:427-443.
14. Berger JR, Concha M: Progressive multifocal leukoencephalopathy. The evolution of a disease once considered rare. J Neurovirol 1995, 1:5-18.
15. Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T: Progressive multifocal leucoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS): a neuropathological autopsy study of 21 cases. Pathol Res Pract 1993, 189:163-173.
16. Von Einsiedel RW, Fife TD, Aksamit AJ, et al.: Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 1993, 240:391-406.
17. Vazeux R, Cumont M, Girard PM, et al.: Severe encephalitis resulting from coinfections with HIV and JC virus. Neurology 1990, 40:944-948.
18. de Luca A, Cingolani A, Linzalone A, et al.: Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 1996, 34:1343-1346.
19. McGuire D, Barhite S, Hollander H, Miles M: JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive mullifocal leukoencephalopathy. Ann Neurol 1995, 37:395-399.
20. Berger JR, Mucke L: Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988, 38:1060-1065.
21. Berger JR: Long term survival in biopsy proven AIDS-associated PML [letter]. J Neurovirol 1996, 2:31.
22. Lortholary O, Pialoux G, Dupont P, et al.: Prolonged survival of a patient with AIDS and progressive multifocal leukoencephalopathy. Clin Infect Dis 1994, 18:826-827.
23. Brooks BR, Walker DL: Progressive multifocal leukoencephalopathy. Neurol Clin 1984, 2:299-313.
24. Hedley-Whyte ET, Smith BP, Tyler HR, Peterson WP: Multifocal leukoencephalopathy with remission and five year survival. J Neuropathol Exp Neurol 1966, 25:107-116.
25. Kepes JJ, Chou SM, Price LW Jr: Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features. Neurology 1975, 25:1006-1012.
26. Selhorst JB, Ducy KF, Thomas JM, Reggelson W: PML: remission and immunologic reversals [letter]. Neurology 1978, 28:337.
27. Stam FC: Multifocal leuko-encephalopathy with slow progression and very long survival. Psychiatr Neurol Neurochir 1966, 69:453-459.
28. Vollmer-Haase J, Young P, Ringelstein EB: Efficacy of camptothecin in progressive multifocal leucoencephalopathy [letter]. Lancet 1997, 349:1366.
29. Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D: Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol 1983, 13:485-490.
30. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR: Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992, 5:49-73.
31. Britton CB, Romagnoli M, Sisti M, Powers JM: Progressive multifocal leukoencephalopathy: disease progression, stabilization and response to intrathecal Ara-C in 26 patients. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract ThB1512].
32. Nicoli F, Chave B, Peragut JC, Gastaut JL: Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992, 339:306.
33. O'Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD: Progressive multifocal leukoencephalopathy: remission with cytarabine. J Infect 1990, 20:51-54.
34. Portegies P, Algra PR, Hollak CE, et al.: Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1991, 337:680-681.
35. Moreno S, Miralles P, Diaz MD, et al.: Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1996, 23:1066-1068.
36. Guarino M, D'Alessandro R, Rinaldi R, et al.: Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside [letter]. AIDS 1995, 9:819-820.
37. Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH: Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993, 33:407-411.
38. Colosimo C, Lebron P, Martelli J, et al.: Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neuro Belg 1992, 92:24-29.
39. Huang S, Skolasky R, Dal Pan G, Royal W, McArthur J: Survival prolongation and symptom palliation in HIV-seropositive patients with PML treated with α-interferon. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1997 [abstract 341].
40. Berger JR, Pall L, McArthur J, et al.: A pilot study of recombinant alpha 2a interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy [abstract]. Neurology 1992, 42 (suppl 3):257.
41. Hall CD, Dafni U, Simpson D, et al.: Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998, 338:1345-1351.
42. Kerr DA, Chang CF, Gordon J, Bjornsti MA, Khalili K: Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 1993, 196:612-618.
43. De Wit S, Snoeck R, Rossi C, et al.: Treatment of progressive multifocal leukoencephalopathy (PML) with cidofovir in an AIDS patient. AIDS 1996, 10 (suppl 2):S45.
44. Conway B, Halliday WC, Brunham RC: Human immunodeficiency virus-associated progressive leukoencephalopathy: apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 1990, 12:479-482.
45. Singer EJ, Stoner GL, Singer P, et al.: Case report. AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine. Acta Neurol Scand 1994, 90:443-447.
46. Garrote FL, Molina JA, Lacambra C, Mollejo M, Madero S, del Ser T: The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS). Rev Clin Esp 1990, 187:404-407.